Press release
Premenstrual Syndrome Treatment Market Size to Reach US$ 1,683 Million By 2028
Premenstrual Syndrome Treatment Market Research Report 2023-2028
Premenstrual syndrome (PMS) treatment represents the therapeutic process utilized for minimizing physical, emotional, and psychological symptoms, such as breast tenderness, body pain, bloating, fatigue, mood fluctuations, and anxiety, in women. It generally involves the use of analgesics, nonsteroidal anti-inflammatory drugs (NSAIDs), antidepressants, diuretics, ovarian suppression agents, hormonal contraceptives, etc. They are commonly available over the counter (OTC) or are prescribed by a doctor. As such, novel PMS treatment drugs, including creams, topical gels, capsules, and suppositories, are manufactured by using extracts for the management of mood imbalances, facilitating muscle relaxation, minimizing uterine cramps, etc.
Request Free Sample Report: https://www.imarcgroup.com/premenstrual-syndrome-treatment-market/requestsample
Premenstrual Syndrome Treatment Market Trends and Drivers:
The growing prevalence of PMS and premenstrual dysphoric disorder (PMDD), owing to the sedentary lifestyles and hectic schedules of the female working population, is primarily driving the premenstrual syndrome treatment market. Additionally, the rising consumer awareness towards available treatment alternatives for PMS and other related disorders is further catalyzing the market growth. Besides this, leading manufacturers are developing medications that have minimal side effects and help in maintaining the appropriate pH balance in the body, which is acting as another significant growth-inducing factor. Moreover, the widespread adoption of nutritional supplements that are produced by using plant-based sources to provide relief from PMS is positively influencing the global market. Apart from this, these supplements contain the recommended amount of nutrients, such as magnesium, calcium, potassium, proteins, etc., that assist in reducing fatigue and easing anxiety and depression. Furthermore, the development of smartphone applications by healthcare organizations that periodically record emotional and physiological changes occurring in the body and send notification alerts as medication reminders is expected to fuel the premenstrual syndrome treatment market over the forecasted period.
Premenstrual Syndrome Treatment Market 2023-2028 Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
AbbVie Inc.
BASF SE
Bayer AG
Reddy's Laboratories Ltd
Eli Lilly and Company.
GlaxoSmithKline Plc.
Lundbeck A/S
Pfizer Inc.
SHIONOGI & Co. Ltd.
The report has segmented the market on the basis on region, drug type, type, distribution channel.
Breakup by Drug Type:
Analgesics
Antidepressants
Oral Contraceptives and Ovarian Suppression Agents
Others
Breakup by Type:
Prescription
Prescription
Breakup by Distribution Channel:
Hospital Pharmacies
Drug Stores and Retail Pharmacies
Online Stores
Breakup by Region:
North America
Asia-Pacific
Europe
Latin America
Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/premenstrual-syndrome-treatment-market
Key highlights of the report:
Market Performance (2017-2022)
Market Outlook (2023-2028)
Porter's Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Browse Top Trending Reports:
https://www.openpr.com/news/3011738/apple-juice-market-2023-2028-share-size-growth-top
https://www.openpr.com/news/3011761/europe-cement-market-report-2023-2028-size-share-industry
https://www.openpr.com/news/3011840/india-cement-market-2023-size-scope-growth-price-trends
https://www.openpr.com/news/3011882/mobile-gaming-market-2023-2028-share-size-growth-top
https://www.openpr.com/news/3011903/factoring-market-size-to-hit-us-5-179-3-billion-by-2028-cagr
https://www.openpr.com/news/3011942/crowdfunding-market-size-to-hit-us-28-9-billion-by-2028-cagr
https://www.openpr.com/news/3011977/digital-map-market-2023-2028-share-size-growth-top
Contact Us:
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Premenstrual Syndrome Treatment Market Size to Reach US$ 1,683 Million By 2028 here
News-ID: 3032240 • Views: …
More Releases from IMARC Group
Australia Truck Market Projected to Reach USD 280.91 Million by 2033
Market Overview
The Australia truck market size was valued at USD 150.00 Million in 2024 and is projected to reach USD 280.91 Million by 2033. This growth is fueled by increasing demand in freight and logistics, sustainability initiatives, government infrastructure investments, and technological advancements. Fleet operators are progressively adopting cleaner and more efficient trucks to meet regulations and environmental expectations. Key trends include electrification, autonomous vehicle technology, and advanced safety systems.…
Australia Patient Handling Equipment Market Projected to Reach USD 451.29 Millio …
Market Overview
The Australia patient handling equipment market was valued at USD 263.87 Million in 2025 and is expected to reach USD 451.29 Million by 2034, growing at a compound annual growth rate of 6.14% during the forecast period of 2026-2034. Expansion is driven by an aging population needing specialized mobility and care, government funding for aged care modernization, and increased focus on workplace safety to reduce caregiver injuries. Technological advancements…
Australia Fermented Superfoods Market Projected to Reach USD 1,515.2 Million by …
Market Overview
The Australia fermented superfoods market attained a size of USD 715.2 Million in 2024 and is forecasted to grow to USD 1,515.2 Million by 2033. The market is expected to achieve this expansion over the forecast period from 2025 to 2033 at a compound annual growth rate of 8.7%. Growth is driven by the rising consumer awareness of gut health and demand for organic, locally sourced ingredients alongside continuous…
Mexico Mixed Xylene Market Size, Growth, Latest Trends and Forecast 2026-2034
IMARC Group has recently released a new research study titled "Mexico Mixed Xylene Market Size, Share, Trends and Forecast by Grade, End Use, and Region, 2026-2034" which offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.
Market Overview
The Mexico mixed xylene market size was valued at USD 924.83 Million in 2025 and is projected to reach USD…
More Releases for Premenstrual
Premenstrual Dysphoric Disorder Market - Revolutionizing Markets | Industry Repo …
15 March 2025, Metatech Insights - Premenstrual Dysphoric Disorder Market industry achieved a market size of USD 1.86 Billion in 2024 and is forecast to climb to USD 2.96 Billion by 2035, fueled by a CAGR of approximately 4.30% throughout 2024-2035.
The Premenstrual Dysphoric Disorder Market Report is the outcome of extensive research and analysis conducted by our team of experienced market researchers. It covers a wide range of critical factors…
Premenstrual Syndrome Treatment Market | $1.5 Billion by 2026 | 3.7% CAGR
Premenstrual syndrome (PMS) treatment market has witnessed exceptional growth over the years. With a robust valuation of $1,129 million in 2018, this dynamic market is poised to soar even higher, reaching an estimated value of $1,516 million by 2026. This remarkable projection reflects a steady compound annual growth rate (CAGR) of 3.7% from 2019 to 2026, underlining the increasing demand for effective PMS treatments.
The growth and success of the PMS…
Premenstrual Syndrome Treatment Market: Increase in Prevalence of PMS and Premen …
Premenstrual Syndrome Treatment Market Outlook 2031
-The global premenstrual syndrome treatment market was valued at US$ 1.3 Bn in 2021
-The global market is projected to grow at a CAGR of 3.4% from 2022 to 2031
-The global premenstrual syndrome treatment market is anticipated to reach more than US$ 1.9 Bn by the end of 2031
Premenstrual Syndrome Treatment Market Introduction
Premenstrual syndrome, or PMS, is the term used to describe a group of physical…
Premenstrual Dysphoric Disorder Market Healthcare, Clinical Reviews, Survey Repo …
Global Premenstrual Dysphoric Disorder Market Research Report 2020-2025, this title divided by product type, applications, industry verticals, and research regions build an in-depth explanation of the perspectives, and comprehensive market statistics. The report presents a thorough analysis of the Premenstrual Dysphoric Disorder Market covering key trends, deployment models, challenges, market drivers, future roadmap, ecosystem player profiles, strategies, and value chain.
(Exclusive Offer: Up to 30% discount on this report)
Get a free…
Premenstrual Dysphoric Disorder Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Premenstrual Dysphoric Disorder Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Premenstrual Dysphoric Disorder players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Premenstrual Dysphoric Disorder with respect…
Premenstrual Syndrome Global Market Research Report 2025
Premenstrual Syndrome Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).
Access more details about this report at: https://www.research2reports.com/report-medical-devices/premenstrual-syndrome-market/80984
The report firstly introduced the Premenstrual Syndrome basics: definitions, classifications, applications and…
